ATXG vs BMRN · $3.7M cap vs P/E 40, rev $1.76B
Addentax Group Corp (ATXG) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Addentax Group Corp (ATXG) is a integrated freight & logistics company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ATXG revenue for 2026-03-31 was $0. Net income was -$4.5M. Revenue was down 100.0% from 2025-03-31 to 2026-03-31. ATXG currently screens at market cap $3.7M.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ATXG currently screens at market cap $3.7M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ATXG and BMRN stock pages for the full models.
Not investment advice.